Der Kardiologe

, Volume 2, Issue 5, pp 363–388

Kommentar zu den „ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death – executive summary“

  • J. Tebbenjohanns
  • S. Willems
  • M. Antz
  • D. Pfeiffer
  • K.-H. Seidl
  • T. Lewalter
Leitlinien

Zusammenfassung

Dieser Kommentar ist eine Übersetzung bzw. Zusammenfassung zu den „ACC/AHA/ESC 2006 Leitlinien zum Management von Patienten mit ventrikulären Arrhythmien und Prävention des plötzlichen Herztodes“. Ziel ist es, den aktuellen Erkenntnisstand zur Thematik zusammenzufassen, versehen mit Kommentaren und der Einordnung in die in Deutschland geübte Praxis. Es wird die gesamte Bandbreite der Thematik hinsichtlich diagnostischer Methoden (EKG, Bildgebung, elektrophysiologische Untersuchung etc.) ebenso dargestellt wie der Stellenwert und die Differenzialindikation medikamentös antiarrhythmischer Therapien, der ICD-Therapie sowie alternativer Verfahren, wie z. B. der Katheterablation. Es wird darüber hinaus spezifisch eingegangen auf die Akutbehandlung ventrikulärer Arrhythmien als auch auf die differenzialtherapeutischen Optionen bei verschiedenen Grunderkrankungen (ischämische Kardiomyopathie, Herzklappenerkrankung, angeborene Herzfehler, Kardiomyopathien, Herzinsuffizienz, genetische Erkrankungen etc.). Insbesondere die zum Teil kontroverse Diskussion hinsichtlich der primärprophylaktischen ICD-Implantation wird im Lichte der vorliegenden Studiendaten kritisch kommentiert.

Schlüsselwörter

Ventrikuläre Arrhythmien Implantierbarer Defibrillator Antiarrhythmika Plötzlicher Herztod 

Comments on the “ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death – executive summary”

Abstract

The purpose of this document is to translate and to comment on the previously published“ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death”. The aim is to update the recommendations for clinical practice in Germany. We address the diagnostic procedures (e.g. ECG, imaging, electrophysiological studies etc.) and therapeutic options (e.g. medical treatment, catheter ablation, implantable cardioverter defibrillator – ICD etc.). Special emphasis was put on management of acute ventricular arrhythmias and on the different treatment modalities for various conditions (e.g. ischemic cardiomyopathy, valvular heart disease, congenital heart disease, non-ischemic cardiomyopathies, congestive heart failure, genetic arrhythmia syndromes etc.). Comments are given in each chapter, including the ongoing debate about ICD indications in primary prophylaxis.

Keywords

Ventricular arrhythmias Implantable cardioverter defibrillator Antiarrhythmics Sudden cardiac death 

Literatur

  1. 1.
    AHA (2005) guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 112: IV1–IV203Google Scholar
  2. 2.
    AHA/ACC/ESC (2006) 2006 guidelines for the management of patients witrh ventricular arrhythmias and the prevention of sudden cardiac death – excecutive summary. Circulation 114: 1088–1132CrossRefGoogle Scholar
  3. 3.
    Amidarone Trials Meta-Analysis Investigators (1997) Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Lancet 350: 1417–1424CrossRefGoogle Scholar
  4. 4.
    Bänsch D, Antz M, Boczor S et al. (2002) Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy trial (CAT). Circulation 105: 1453–1458PubMedCrossRefGoogle Scholar
  5. 5.
    Bardy GH, Lee KL, Mark DB et al. (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352: 225–237PubMedCrossRefGoogle Scholar
  6. 6.
    Boutitie F, Boissel JP, Connolly SJ et al. (1999) Amiodarone interaction with beta-blockers: analysis of the merged EMIAT (European Myocardial Infarct Amiodarone Trial) A CAMIAT (Canadian Myocardial Infarct Amiodarone Trial) databases. The EMIAT and CAMIAT Investigators. Circulation 99: 2268–2275PubMedGoogle Scholar
  7. 7.
    Brugada P, Brugada J (1992) Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 20: 1391–1396PubMedCrossRefGoogle Scholar
  8. 8.
    Buxton AE, Lee KL, Fisher JD et al. (1999) A randomised study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 341: 1882–1890PubMedCrossRefGoogle Scholar
  9. 9.
    Carnendran L, Steinberg JS (2000) Does an open infarct-related artery after myocardial infarction improve electrical stability? Prog Cardiovasc Dis 42: 439–454PubMedCrossRefGoogle Scholar
  10. 10.
    Cazeau S, Leclercq C, Lavergne T et al. (2001) Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 344: 873–880PubMedCrossRefGoogle Scholar
  11. 11.
    Cleland JG, Ghosh J, Freemantle N et al. (2004) Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failure. Eur J Heart Fail 6: 501–508PubMedCrossRefGoogle Scholar
  12. 12.
    Connolly SJ (1999) Meta-analysis of antiarrhythmic drug trials. Am J Cardiol 84: 90R–93RPubMedCrossRefGoogle Scholar
  13. 13.
    Connolly SJ, Dorian P, Roberts RS et al. (2006) Comparison of beta-blockers, amiodaron plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. JAMA 295: 165–171PubMedCrossRefGoogle Scholar
  14. 14.
    Cox GF, Kunkel LM (1997) Dystrophies and heart syndrome. Curr Opin Cardiol 12: 329–343PubMedCrossRefGoogle Scholar
  15. 15.
    Dec GW, Fuster V (1994) Idiopathic dilated cardiomyopathy. N Engl J Med 331: 1564–1575PubMedCrossRefGoogle Scholar
  16. 16.
    De Vreede-Swagemakers JJ, Gorgels AP, Dubois-Arbouw WI et al. (1997) Out-of-hospital cardiac arrest in the 1990’s: a population based study in the Maastricht area on incidence, characteristics, and survival. J Am Coll Cardiol 30: 1500–1505CrossRefGoogle Scholar
  17. 17.
    Doval HC, Nul DR, Grancelli HO et al. (1994) Randomised trial of low-dose amiodarone in severe congestive heart failure. Lancet 344: 493–498PubMedCrossRefGoogle Scholar
  18. 18.
    Ellison KE, Hafley GE, Hickey K et al. (2002) Effect of beta-blocking therapy on outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT). Circulation 106: 2694–2699PubMedCrossRefGoogle Scholar
  19. 19.
    Ezekowitz JA, Armstrong PW, McAlister FA et al. (2003) Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials. Ann Intern Med 138: 445–452PubMedGoogle Scholar
  20. 20.
    Farre J, Romero J, Rubio JM et al. (1999) Amiodarone and „primary“ prevention of sudden death: critical review of a decade of clinical trials. Am J Cardiol 83: 55D–63DPubMedCrossRefGoogle Scholar
  21. 21.
    Freedman RA, Swerdlow C, Soderholm-Difatte V et al. (1988) Prognostic significance of arrhythmia inducibility or noninducibility at initial electrophysiologic study in survivors of cardiac arrest. Am J Cardiol 61: 578–582PubMedCrossRefGoogle Scholar
  22. 22.
    Gibbons RJ, Balady GJ, Bricker JT et al. (2002) ACC/AHA 2002 guideline update for excercise testing: summary article. J Am Coll Cardiol 40: 1531–1540PubMedCrossRefGoogle Scholar
  23. 23.
    Hillis LD, Cigarroa JE, Lange RA (1999) Late revascularization reduces mortality in survivors of myocardial infarction. Cardiol Rev 7: 144–148PubMedCrossRefGoogle Scholar
  24. 24.
    Hoppe UC, Böhm M, Dietz R et al (2005) Leitlinien zur Therapie der chronischen Herzinsuffizienz. Z Kardiol 94: 488–509PubMedCrossRefGoogle Scholar
  25. 25.
    Janse MJ, Malik M, Camm AJ et al. (1998) Identification of post acute myocardial infarction patients with potential benefit from prophylactic treatment with amiodarone. A substudy of EMIAT (the European Myocardial Infarct Amiodarone Trial). Eur Heart J 19: 85–95PubMedCrossRefGoogle Scholar
  26. 26.
    Jung W, Andresen D, Block M et al (2006) Leitlinien zur Implantation von Defibrillatoren. Clin Res Cardiol 95: 696–708PubMedCrossRefGoogle Scholar
  27. 27.
    Kadish A, Dyer A, Daubert JP et al. (2004) Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350: 2151–2158PubMedCrossRefGoogle Scholar
  28. 28.
    Kimbrough J, Moss AJ, Zareba W et al. (2001) Clinical implications for affected parents and siblings of probands with long-QT syndrome. Circulation 104: 557–562PubMedCrossRefGoogle Scholar
  29. 29.
    Klemm HU, Ventura R, Steven D et al. (2007) Catheter ablation of multiple ventricular tachycardias after myocardial infarction guided by combined contact and noncontact mapping. Circulation 115: 2697–2704PubMedCrossRefGoogle Scholar
  30. 30.
    Kliegel A, Eisenburger P, Sterz F et al. (2002) Survivors of ventricular tachyarrhythmias due to a transient or reversible disorder have a high recurrence rate of lethal cardiac events. Resuscitation 54: 237–243PubMedCrossRefGoogle Scholar
  31. 31.
    Kuck KH, Ernst S, Dorwarth U et al. (2007) Leitlinien zur Katheterablation. Clin Res Cardiol 96: 833–849PubMedCrossRefGoogle Scholar
  32. 32.
    Lee DS, Green LD, Liu PP et al. (2003) Effectiveness of implantable defibrillators for preventing arrhythmic events and death: a metaanalysis. J Am Coll Cardiol 41: 1573–1582PubMedCrossRefGoogle Scholar
  33. 33.
    Leenhardt A, Lucet V, Denjoy I et al. (1995) Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up to 21 patients. Circulation 91: 1512–1519PubMedGoogle Scholar
  34. 34.
    Lemke B, Nowak B, Pfeiffer D (2005) Leitlinien zur Herzschrittmachertherapie. Z Kardiol 94: 704–720PubMedCrossRefGoogle Scholar
  35. 35.
    Leon AR, Abraham WT, Curtis AB et al. (2005) Safety of tranvenous cardiac resynchronisation system implantation in patients with chronic heart failure: combined results of over 2000 patients from a multicenter study program. J Am Coll Cardiol 46: 2348–2356PubMedCrossRefGoogle Scholar
  36. 36.
    Luu M, Stevenson WG, Stevenson LW et al. (1989) Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation 80: 1675–1680PubMedGoogle Scholar
  37. 37.
    Marenco JP, Wang PJ, Link MS et al. (2001) Improving survival from sudden cardiac arrest: the role of the automated external defibrillator. JAMA 285: 1193–1200PubMedCrossRefGoogle Scholar
  38. 38.
    Maron BJ, McKenna WJ, Danielson GK et al. (2003) ACC/ESC clinical expert consensus document on hypertrophic cardiomyopathy. J Am Coll Cardiol 42: 1687–1713PubMedCrossRefGoogle Scholar
  39. 39.
    Maron BJ, Zipes DP (2005) Introduction: eligibility recommendations for competitive athletes with cardiovascular abnormalities-general considerations. J Am Coll Cardiol 45: 1318–1321PubMedCrossRefGoogle Scholar
  40. 40.
    Maron B, Spirito P, Shen WK et al. (2007) Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA 298: 405–412PubMedCrossRefGoogle Scholar
  41. 41.
    Meyerburg RJ, Kessler KM, Castellanos A (1993) Sudden cardiac death: epidemiology, transient risk, and intervention assessment. Ann Intern Med 119: 1187–1197Google Scholar
  42. 42.
    Mittal S, Iwai S, Stein KM et al. (1999) Long-term outcome of patients with unexplained syncope treated with an electrophysiologic-guided approach in the implantable cardioverter-defibrillator era. J Am Coll Cardiol 34: 1082–1089PubMedCrossRefGoogle Scholar
  43. 43.
    Moss AJ, Schwartz PJ, Crampton RS et al. (1991) The long QT syndrome. Prospective longitudinal study of 328 families. Circulation 84: 1136–1144PubMedGoogle Scholar
  44. 44.
    Moss AJ, Hall WJ, Cannom DS et al. (1996) Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 335: 1933–1940PubMedCrossRefGoogle Scholar
  45. 45.
    Morady F, Harvey M, Kalbfleisch SJ et al. (1993) Radiofrequency catheter ablation of ventricular tachycardia in patients with coronary artery disease. Circulation 87: 363–372PubMedGoogle Scholar
  46. 46.
    Moss AJ, Zareba W, Hall WJ et al. (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346: 877–883PubMedCrossRefGoogle Scholar
  47. 47.
    Nolan JP, Deakin CD, Soar J et al. (2005) European Resusciatation Council guidelines for resuscitation 2005. Section 4. Adult advanced life support. Resuscitation (Suppl 1) 67: S39–S86Google Scholar
  48. 48.
    Pacifico A, Hohnloser SH, Williams JH et al. (1999) Prevention of implantable-defibrillator shocks by treatment with sotalol. d,1-Sotalol Implantable Cardioverter-Defibrillator Study Group. N Engl J Med 340: 1855–1862PubMedCrossRefGoogle Scholar
  49. 49.
    Pappone C, Santinelli V, Manguso F et al. (2003) A randomized study of prophylactic catheter ablation in asymptomatic patients with the Wolff-Parkinson-White syndrome. N Engl J Med 349: 1803–1811PubMedCrossRefGoogle Scholar
  50. 50.
    Priori SG, Schwartz PJ, Napolitano C et al. (2003) Risk stratification in the long-QT syndrome. N Engl J Med 348: 1866–1874PubMedCrossRefGoogle Scholar
  51. 51.
    Priori SG, Bossaert LL, Chamberlain DA et al. (2004) ESC-ERC recommendations for the use of automated external defibrillators (AEDs) in Europe. Eur Heart J 25: 437–445PubMedCrossRefGoogle Scholar
  52. 52.
    Reddy VY, Reynolds MR, Neuzil P et al. (2007) Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 357: 2657–2665PubMedCrossRefGoogle Scholar
  53. 53.
    Reiter MJ, Reiffel JA (1998) Importance of beta blockade in the therapy of serious ventricular arrhythmias. Am J Cardiol 82: 9I–19IPubMedCrossRefGoogle Scholar
  54. 54.
    Ross DL, Farr J, Bar FW et al. (1980) Comprehensive clinical electrophysiologic studies in the investigation of documented or suspect tachycardias. Time, staff, problems and costs. Circulation 61: 1010–1016PubMedGoogle Scholar
  55. 55.
    Schrickel JW, Schwab JO, Yang A et al. (2006) Pro-arrhythmic effects of amiodarone and concomitant rate-control medication. Europace 8: 403–407PubMedCrossRefGoogle Scholar
  56. 56.
    Seidl K, Schuchert A, Tebbenjohanns J, Hartung W (2005) Kommentar zu den Leitlinien zur Diagnostik und Therapie von Synkopen – der Europäischen Gesellschaft für Kardiologie 2001 und dem Update 2004. Z Kardiol 94: 592–612PubMedCrossRefGoogle Scholar
  57. 57.
    Silva RM, Mont L, Nava S et al. (2004) Radiofrequency catheter ablation for arrhythmic storm in patients with an implantable cardioverter defibrillator. Pacing Clin Electrophysiol 27: 9761–9765CrossRefGoogle Scholar
  58. 58.
    Singh SN, Fletcher RD, Fisher SG et al. (1995) Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med 333: 493–498Google Scholar
  59. 59.
    Splawski I, Timothy KW, Sharpe LM et al. (2004) Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119: 19–31PubMedCrossRefGoogle Scholar
  60. 60.
    Spirito P, Bellone P, Harris KM et al. (2000) Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 342: 1778–1785PubMedCrossRefGoogle Scholar
  61. 61.
    Steinberg JS, Martins J, Sadanadan S et al. (2001) Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study. Am Heart J 142: 520–529PubMedCrossRefGoogle Scholar
  62. 62.
    Strickberger SA, Hummel JD, Bartlett TG et al. (2003) Amiodarone versus implantable cardioverter-defibrillator: randomised trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia-AMIOVERT. J Am Coll Cardiol 41: 1707–1712PubMedCrossRefGoogle Scholar
  63. 63.
    Takemoto MJ, Yoshimura H, Ohba Y et al. (2005) Radiofrequency catheter ablation of premature ventricular complexes from right ventricular outflow tract improves left ventricular dilation and clinical status in patients without structural heart disease. J Am Coll Cardiol 45: 1259–1265PubMedCrossRefGoogle Scholar
  64. 64.
    The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators (1997) A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated form near-fatal ventricular arrhythmias. N Engl J Med 337: 1576–1583CrossRefGoogle Scholar
  65. 65.
    Trappe HJ, Andresen D, Arntz HR (2005) Positionspapier zur „Automatisierten Externen Defibrillation. Z Kardiol 94: 287–295PubMedCrossRefGoogle Scholar
  66. 66.
    Wilber DJ, Garan H, Finkelstein D et al. (1988) Out-of-hospital cardiac arrest. Use of electrophysiologic testing in the prediction of long-term outcome. N Engl J Med 318: 19–24PubMedGoogle Scholar
  67. 67.
    Willems S, Eckhardt L, Hoffmann E et al. (2007) Leitlinie invasive elektrophysiologische Diagnostik. Clin Res Cardiol 96: 634–651PubMedCrossRefGoogle Scholar
  68. 68.
    Wyse DG, Friedman PL, Brodsky MA et al. (2001) Life-threatening ventricular arrhythmias due to transient or correctable causes: high risk for death in follow-up. J Am Coll Cardiol 38: 1718–1724PubMedCrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag 2008

Authors and Affiliations

  • J. Tebbenjohanns
    • 1
  • S. Willems
    • 2
  • M. Antz
    • 3
  • D. Pfeiffer
    • 4
  • K.-H. Seidl
    • 5
  • T. Lewalter
    • 6
  1. 1.Med.-Klinik I – Kardiologie, Angiologie, IntensivmedizinKlinikum Hildesheim GmbHHildesheimDeutschland
  2. 2.Klinik für KardiologieUniversitäres Herzzentrum GmbHHamburgDeutschland
  3. 3.Abteilung für ElektrophysiologieKlinikum Oldenburg gGmbHOldenburgDeutschland
  4. 4.Zentrum für Innere MedizinUniversitätsklinium LeipzigLeipzigDeutschland
  5. 5.Medizinische Klinik BKlinikum der Stadt LudwigshafenLudwigshafenDeutschland
  6. 6.Med. Klinik II – Kardiologie, IntensivmedizinSt. Vincens-KrankenhausPaderbornDeutschland

Personalised recommendations